VANGUARD GROUP INC 13D and 13G filings for Avadel Pharmaceuticals plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-29 3:01 pm Unchanged | 2025-06-30 | 13G | Avadel Pharmaceuticals plc AVDL | VANGUARD GROUP INC | 5,564,259 5.740% | 0 (Unchanged) | Filing |
| 2025-07-29 3:00 pm Purchase | 2025-06-30 | 13G | Avadel Pharmaceuticals plc AVDL | VANGUARD GROUP INC | 5,564,259 5.740% | 5,564,259 (New Position) | Filing |